133814-19-4 Usage
Originator
Mivacron,GlaxoSmithKline S.p.A.,Italy
Therapeutic Function
Muscle relaxant
Clinical Use
#N/A
Drug interactions
Potentially hazardous interactions with other drugs
Anaesthetics: enhanced muscle relaxant effect.
Anti-arrhythmics: procainamide enhances muscle
relaxant effect.
Antibacterials: effect enhanced by aminoglycosides,
clindamycin, polymyxins and piperacillin.
Antiepileptics: muscle relaxant effects antagonised by
carbamazepine; effects reduced by long-term use of
fosphenytoin and phenytoin but might be increased
by acute use.
Botulinum toxin: neuromuscular blockade enhanced,
(risk of toxicity).
Metabolism
Mivacurium is a mixture of 3 stereoisomers, 2 of which
(cis-trans and trans-trans) are considered to account for
most of the neuromuscular blocking effect. All 3 isomers
are inactivated by plasma cholinesterase.
Renal and hepatic mechanisms are involved in their
elimination with excretion in urine and bile.
Check Digit Verification of cas no
The CAS Registry Mumber 133814-19-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,3,8,1 and 4 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 133814-19:
(8*1)+(7*3)+(6*3)+(5*8)+(4*1)+(3*4)+(2*1)+(1*9)=114
114 % 10 = 4
So 133814-19-4 is a valid CAS Registry Number.